Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Front Chem ; 7: 9, 2019.
Article in English | MEDLINE | ID: mdl-30834240

ABSTRACT

Halogen bonds have recently gained attention in life sciences and drug discovery. However, it can be difficult to harness their full potential, when newly introducing them into an established hit or lead structure by molecular design. A possible solution to overcome this problem is the use of halogen-enriched fragment libraries (HEFLibs), which consist of chemical probes that provide the opportunity to identify halogen bonds as one of the main features of the binding mode. Initially, we have suggested the HEFLibs concept when constructing a focused library for finding p53 mutant stabilizers. Herein, we broaden and extent this concept aiming for a general HEFLib comprising a huge diversity of binding motifs and, thus, increasing the applicability to various targets. Using the construction principle of feature trees, we represent each halogenated fragment by treating all simple to complex substituents as modifiers of the central (hetero)arylhalide. This approach allows us to focus on the proximal binding interface around the halogen bond and, thus, its integration into a network of interactions based on the fragment's binding motif. As a first illustrative example, we generated a library of 198 fragments that unifies a two-fold strategy: Besides achieving a diversity-optimized basis of the library, we have extended this "core" by structurally similar "satellite compounds" that exhibit quite different halogen bonding interfaces. Tuning effects, i.e., increasing the magnitude of the σ-hole, can have an essential influence on the strength of the halogen bond. We were able to implement this key feature into the diversity selection, based on the rapid and efficient prediction of the highest positive electrostatic potential on the electron isodensity surface, representing the σ-hole, by VmaxPred.

2.
J Chem Inf Model ; 59(2): 885-894, 2019 02 25.
Article in English | MEDLINE | ID: mdl-30629432

ABSTRACT

Halogen bonds have become increasingly popular interactions in molecular design and drug discovery. One of the key features is the strong dependence of the size and magnitude of the halogen's σ-hole on the chemical environment of the ligand. The term σ-hole refers to a region of lower electronic density opposite to a covalent bond, e.g., the C-X bond. It is typically (but not always) associated with a positive electrostatic potential in close proximity to the extension of the covalent bond. Herein, we use a variety of 30 nitrogen-bearing heterocycles, halogenated systematically by chlorine, bromine, or iodine, yielding 468 different ligands that are used to exemplify scaffold effects on halogen bonding strength. As a template interaction partner, we have chosen N-methylacetamide representing the ubiquitously present protein backbone. Adduct formation energies were obtained at a MP2/TZVPP level of theory. We used the local maximum of the electrostatic potential on the molecular surface in close proximity to the σ-hole, V S,max, as a descriptor for the magnitude of the positive electrostatic potential characterizing the tuning of the σ-hole. Free optimization of the complexes gave reasonable correlations with V S,max but was found to be of limited use because considerable numbers of chlorinated and brominated ligands lost their halogen bond or showed significant secondary interactions. Thus, starting from a close to optimal geometry of the halogen bond, we used distance scans to obtain the best adduct formation energy for each complex. This approach provided superior results for all complexes exhibiting correlations with R2 > 0.96 for each individual halogen. We evaluated the dependence of V S,max from the molecular surface onto which the positive electrostatic potential is projected, altering the isodensity values from 0.001 au to 0.050 au. Interestingly, the best overall fit using a third-order polynomial function (R2 = 0.99, RMSE = 0.562 kJ/mol) with rather smooth transitions between all halogens was obtained for V S,max calculated from an isodensity surface at 0.014 au.


Subject(s)
Halogens/chemistry , Drug Discovery , Halogenation , Heterocyclic Compounds/chemistry , Models, Molecular , Molecular Conformation , Nitrogen/chemistry , Quantum Theory , Static Electricity , Surface Properties , Thermodynamics
3.
J Chem Inf Model ; 59(2): 636-643, 2019 02 25.
Article in English | MEDLINE | ID: mdl-30582814

ABSTRACT

Halogen bonding as a modern molecular interaction has received increasing attention not only in materials sciences but also in biological systems and drug discovery. Thus, there is a growing demand for fast, efficient, and easily applicable tailor-made tools supporting the use of halogen bonds in molecular design and medicinal chemistry. The potential strength of a halogen bond is dependent on several properties of the σ-hole donor, e.g., a (hetero)aryl halide, and the σ-hole acceptor, a nucleophile with n or π electron density. Besides the influence of the interaction geometry and the type of acceptor, significant tuning effects on the magnitude of the σ-hole can be observed, caused by different (hetero)aromatic scaffolds and their substitution patterns. The most positive electrostatic potential on the isodensity surface ( Vmax), representing the σ-hole, has been widely used as the standard descriptor for the magnitude of the σ-hole and the strength of the halogen bond. Calculation of Vmax using quantum-mechanical methods at a reasonable level of theory is time-consuming and thus not applicable for larger numbers of compounds in drug discovery projects. Herein we present a tool for the prediction of this descriptor based on a machine-learned model with a speedup of 5 to 6 orders of magnitude relative to MP2 quantum-mechanical calculations. According to the test set, the squared correlation coefficient is greater than 0.94.


Subject(s)
Drug Discovery/methods , Halogens/chemistry , Quantum Theory , Models, Molecular , Molecular Conformation , Time Factors
4.
Front Chem ; 6: 484, 2018.
Article in English | MEDLINE | ID: mdl-30386769

ABSTRACT

Phage display-selected bicyclic peptides have already shown their great potential for the development as bioactive modulators of therapeutic targets. They can provide enhanced proteolytic stability and improved membrane permeability. Molecular design of new linker molecules has led to a variety of new synthetic approaches for the generation of chemically constrained cyclic peptides. This diversity can be useful for the development of novel peptide-based therapeutic, diagnostic, and scientific tools. Herein, we introduce 1,3,5-tris((pyridin-2-yldisulfanyl)methyl)benzene (TPSMB) as a planar, trivalent, sulfhydryl-specific linker that facilitates reversible cyclization and linearization via disulfide bond formation and cleavage of bicyclic peptides of the format CXnCXnC, where X is any proteinogenic amino acid except cysteine. The rapid and highly sulfhydryl-specific reaction of TPSMB under physiological conditions is demonstrated by selecting bicyclic peptide binders against c-Jun N-terminal kinase 3 (JNK3) as a model target. While model peptides remain stably cyclized for several hours in presence of typical blood levels of glutathione in vitro, high cytosolic concentrations of glutathione linearize these peptides completely within 1 h. We propose that reversible linkers can be useful tools for several technical applications where target affinity depends on the bicyclic structure of the peptide.

6.
J Am Chem Soc ; 137(46): 14640-52, 2015 Nov 25.
Article in English | MEDLINE | ID: mdl-26505827

ABSTRACT

We target the gatekeeper MET146 of c-Jun N-terminal kinase 3 (JNK3) to exemplify the applicability of X···S halogen bonds in molecular design using computational, synthetic, structural and biophysical techniques. In a designed series of aminopyrimidine-based inhibitors, we unexpectedly encounter a plateau of affinity. Compared to their QM-calculated interaction energies, particularly bromine and iodine fail to reach the full potential according to the size of their σ-hole. Instead, mutation of the gatekeeper residue into leucine, alanine, or threonine reveals that the heavier halides can significantly influence selectivity in the human kinome. Thus, we demonstrate that, although the choice of halogen may not always increase affinity, it can still be relevant for inducing selectivity. Determining the crystal structure of the iodine derivative in complex with JNK3 (4X21) reveals an unusual bivalent halogen/chalcogen bond donated by the ligand and the back-pocket residue MET115. Incipient repulsion from the too short halogen bond increases the flexibility of Cε of MET146, whereas the rest of the residue fails to adapt being fixed by the chalcogen bond. This effect can be useful to induce selectivity, as the necessary combination of methionine residues only occurs in 9.3% of human kinases, while methionine is the predominant gatekeeper (39%).


Subject(s)
Chalcogens/chemistry , Halogens/chemistry , Methionine/metabolism , Mitogen-Activated Protein Kinase 10/chemistry , Crystallography, X-Ray , Fluorescence Polarization
7.
Bioorg Med Chem ; 23(15): 4324-4332, 2015 Aug 01.
Article in English | MEDLINE | ID: mdl-26142319

ABSTRACT

Unspecific peroxygenases (UPOs, EC 1.11.2.1) have proved to be stable oxygen-transferring biocatalysts for H2O2-dependent transformation of pharmaceuticals. We have applied UPOs in a drug development program and consider the enzymatic approach in parallel to a conventional chemical synthesis of the human metabolites of the bile acid reabsorption inhibitor SAR548304. Chemical preparation of N,N-di-desmethyl metabolite was realized by a seven-step synthesis starting from a late precursor of SAR548304 and included among others palladium catalysis and laborious chromatographic purification with an overall yield of 27%. The enzymatic approach revealed that the UPO of Marasmius rotula is particularly suitable for selective N-dealkylation of the drug and enabled us to prepare both human metabolites via one-pot conversion with an overall yield of 66% N,N-di-desmethyl metabolite and 49% of N-mono-desmethylated compound in two separated kinetic-controlled reactions.


Subject(s)
Glucosamine/analogs & derivatives , Heterocyclic Compounds/chemistry , Marasmius/enzymology , Mixed Function Oxygenases/metabolism , Phenylurea Compounds/chemical synthesis , Catalysis , Glucosamine/chemical synthesis , Glucosamine/chemistry , Glucosamine/metabolism , Heterocyclic Compounds/chemical synthesis , Humans , Hydrogen Peroxide/chemistry , Palladium/chemistry , Phenylurea Compounds/chemistry , Phenylurea Compounds/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...